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Background: Ca2+ influx through CaV1.1 is not required for skeletal muscle excitation-contraction coupling, but
whether Ca2+ permeation through CaV1.1 during sustained muscle activity plays a functional role in mammalian
skeletal muscle has not been assessed.
Methods: We generated a mouse with a Ca2+ binding and/or permeation defect in the voltage-dependent Ca2+
channel, CaV1.1, and used Ca
2+ imaging, western blotting, immunohistochemistry, proximity ligation assays, SUnSET
analysis of protein synthesis, and Ca2+ imaging techniques to define pathways modulated by Ca2+ binding and/or
permeation of CaV1.1. We also assessed fiber type distributions, cross-sectional area, and force frequency and fatigue
in isolated muscles.
Results: Using mice with a pore mutation in CaV1.1 required for Ca
2+ binding and/or permeation (E1014K, EK), we
demonstrate that CaV1.1 opening is coupled to CaMKII activation and refilling of sarcoplasmic reticulum Ca
2+ stores
during sustained activity. Decreases in these Ca2+-dependent enzyme activities alter downstream signaling pathways
(Ras/Erk/mTORC1) that lead to decreased muscle protein synthesis. The physiological consequences of the permeation
and/or Ca2+ binding defect in CaV1.1 are increased fatigue, decreased fiber size, and increased Type IIb fibers.
Conclusions: While not essential for excitation-contraction coupling, Ca2+ binding and/or permeation via the CaV1.1
pore plays an important modulatory role in muscle performance.
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Excitation-contraction coupling (ECC) in skeletal muscle
involves a mechanical interaction between the L-type
voltage-dependent Ca2+ channel (CaV1.1) and the sarco-
plasmic reticulum (SR) Ca2+ release channel (the ryano-
dine receptor, RyR1). Although Ca2+ entry through CaV1.1
is not required for skeletal muscle ECC [1], CaV1.1 opens
after the initial voltage-gated release event to allow Ca2+
to both bind and permeate the channel pore [2]. Like
other voltage-dependent Ca2+ channels, CaV1.1 undergoes* Correspondence: susanh@bcm.edu
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unless otherwise stated.multiple conformational changes driven by membrane
depolarization and/or Ca2+ movement (and/or binding)
through the channel [3,4]. The opening of CaV1.1 actually
occurs after the opening of RyR1 [5], and CaV1.1 has been
suggested to facilitate RyR1 closing [6]. Although there is
only limited understanding of the role of Ca2+ permeation
via CaV1.1, this influx has been suggested to regulate clus-
tering of nicotinic acetylcholine receptors at the neuro-
muscular junction [7-9] and muscle plasticity [10].
Alterations in Ca2+ binding and permeation through
CaV1.1 contribute to the pathological development of
several muscle diseases [11-14]. Mutations in both RyR1
and CaV1.1 are associated with malignant hyperthermia
(MH) in humans. The CaV1.1 mutations either enhanceis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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destabilize a closed state of RyR1. At least one of these
MH mutations (R174W) ablates the L-type current and
increases the sensitivity of RyR1 to caffeine, but does not
alter ECC, demonstrating that the disease mechanism
involves a distinct role for CaV1.1 [15]. Together, these
findings suggest a more extensive role for Ca2+ perme-
ation via CaV1.1 in muscle function than what is presently
understood.
In skeletal muscle, as in most cells, Ca2+ regulates
multiple signaling pathways depending on the ampli-
tude, frequency, duration, and location of the Ca2+ sig-
nal (reviewed by Tavi and Westerblad [16]). CaMKII is
a major integrator of local Ca2+ signals that exhibits a
privileged interaction with L-type channels (CaV1.x) due
to its ability to cluster nearby and, upon Ca2+ binding, to
interact with CaV1.x channels [17]. CaV1.x channels prevail
over other Ca2+ influx channels with respect to trans-
ducing excitation-transcription coupling (ETC) [18,19].
Hudmon et al. [17] demonstrated that CaMKII tethers to
CaV1.2 and phosphorylates the carboxy-terminal tail of
the α1 subunit to increase Ca
2+ influx. The interaction of
CaMKII with CaV1.2, in turn, facilitates CaMKII auto-
phosphorylation.
To directly delineate the role of Ca2+ permeation
through CaV1.1 in skeletal muscle function, we created a
mouse with a Ca2+ binding and permeation defect in
CaV1.1. We demonstrate that this CaV1.1-mediated
pathway utilizes the flexibility of Ca2+ signaling (location,
frequency, duration, and amplitude) to regulate CaMKII
and calcineurin activation, thereby enhancing SR Ca2+
store refilling and protein synthesis to modulate fatigue
susceptibility, muscle size, and fiber type distribution.
Methods
Materials
N-benzyl-p-toluene sulfonamide (BTS) was purchased
from Tocris Biosciences (Bristol/UK, England), latrunculin
A from AdipoGen (San Diego/California, United States),
and 4-chloro-m-cresol (4CmC) from Pfaltz & Bauer (West
Chester/Pennsylvania, United States). The calcium dyes
fura-2 AM and mag-fluo-4 AM were purchased from
Invitrogen (Grand Island/New York, United States). Mo-
lecular weight marker for western blotting was purchased
from GenDEPOT (Barker/TX, United States). Every other
reagent including Insulin, KN-92, KN-93, and the myris-
toylated autocamtide 2-related inhibitory peptide (AIP)
were purchased from Sigma-Aldrich (St. Louis, United
States).
Animals
In this study, male mice between six and 12 weeks old
were used (The mice were generated by the Hamilton
lab and backcrossed with the C57BL/6 J mice obtainedfrom Jackson’s Laboratory (Bar Harbor/Maine, United
States)), unless otherwise indicated. All mice were housed
at room temperature with a 12:12 hour light-dark cycle
and provided with food and water ad libitum. All proce-
dures were approved by the Animal Care Committees at
Baylor College of Medicine (Texas, United States) and the
University of Rochester (New York, United States).
Creation of E1014K mice
The EK mutation was engineered on a genomic fragment
of about 500 bp containing the exon-encoding residue
E1014. A tetracycline resistance gene cassette (tet, for bac-
teria selection) and a neomycin cassette (neo, for ES cell
selection) were inserted into the middle of the engineered
fragment, flanked by about 250 bp homologies to CaV1.1.
This selection marker-containing fragment was used to
isolate a larger CaV1.1 genomic clone from a mouse 129
phage library via homologous recombination in Escheri-
chia coli [20]. Several clones were isolated and we chose
one with an appropriate length of homologies on each
side of the two cassettes for electroporation into AB2.2 ES
from the 129SvEv cells. Recombinant ES clones were iden-
tified using southern blot analysis, and one of the clones
was injected into blastocysts derived from C57BL/6 J mice
to produce chimeras. The targeted allele was germ-line
transmitted and the two selection cassettes were removed
through crosses with Meox2-Cre mice [21].
To expedite the transfer of the E1014K mutation from
the 129SvEv mouse sub-strain background to a congenic
C57BL/6 J background, speed congenics were used, in
addition to conventional backcrossing. We identified 92
microsatellites of maximal base-pair length disparity
between the 129SvEv and C57BL/6 J strains. These micro-
satellites were chosen to representatively span the entire
genome and show distinct electrophoretic separation. Pri-
mer pairs were selected to PCR amplify the chosen micro-
satellites to be resolved by electrophoresis in Spreadex
EL300 Wide Mini Gels (Elchrom Scientific, Cham,
Switzerland). Finally, we compared 129SvEv and C57BL/6 J
DNA standards to DNA from our backcrossed mice, and
selected mice with the most sequence homology to
C57BL/6 J DNA to be used in the next backcross. This
method both ensured congenicity between the wild-type
(WT) and EK mutant mice and provided a means to more
quickly begin experimentation.
Isolation of flexor digitorum brevis muscle fibers
Skeletal muscle fibers were isolated from the flexor digi-
torum brevis (FDB) muscle obtained from WT and EK
mice as described [22].
Whole-cell patch clamp recordings of CaV1.1 currents
The whole-cell patch clamp technique was used to assess
CaV1.1 currents (ICa) in FDB fibers isolated from WT and
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solution containing (in mM): 157 TEA-methanesulfonate,
2 CaCl2, 10 HEPES, 0.5 anthracene-9-carboxylic acid
(9-AC), and 0.1 BTS, at pH 7.4, adjusted with TEA-OH.
The patch pipette internal solution contained (in mM):
140 Cs-methanesulfonate, 10 HEPES, 20 Na-EGTA, and 4
MgCl2, at pH 7.4, adjusted with CsOH. All reagents here
were purchased from Sigma Aldrich (St. Louis/Missouri,
United States). The patch pipette resistance when placed
in the external solution was between 0.6 and 1.0 Mohm.
Fibers were voltage-clamped at a holding potential
of −80 mV. Series resistance was compensated up to 80%.
Data were sampled every 120 μs and filtered using a
low pass Bessel filter (Axon Instrument, Jakarta/Selatan,
Indonesia) with a 2 kHz cut-off frequency. ICa was activated
by 200 ms depolarizing pulses ranging from −40 mV
to +60 mV in 10 mV increments delivered every
10 seconds. CaV1.1 current-voltage relationships (ICa-V)
were obtained from peak currents measured during each
depolarization normalized to cell capacitance and plotted
against the corresponding test potential. ICa-V data were
then fitted by the following modified Boltzman equation:
Vð Þ ¼ Gmax  V‐Vrevð Þ= 1 þ exp V0:5– Vð Þ=kg
   ð1Þ
where Gmax is the maximal L-channel conductance, V is
test potential, Vrev is the L-channel reversal potential,
V0.5 is the potential for half-maximal activation of Gmax,
and kg is a slope factor.
CaV1.1 currents were analyzed using Igor Pro 6 (Lake
Oswego, Oregon, United States) and Clampfit 9 (Sunnyvale,
California, United States) software.
Measurements of electrically-evoked Ca2+ release in flexor
digitorum brevis muscle fibers stimulated during a single
twitch
Acutely isolated FDB fibers were loaded for 20 minutes
at room temperature with 4 μM mag-fluo-4 AM in a
Kreb’s Ringer solution containing (in mM): 146 NaCl, 5
KCl, 2 CaCl2, 1 MgCl2, and 10 HEPES, at pH 7.4. Fibers
were then washed and incubated for 20 minutes in
dye-free Ringer’s solution supplemented with 20 μM
BTS, a skeletal muscle myosin inhibitor, to block contrac-
tion. Mag-fluo-4 AM-loaded FDB fibers were excited at
480 ± 15 nm and fluorescence emission detected at
535 ± 20 nm was collected at 10 kHz using a photo-
multiplier system. Electrical field stimulation (8 V,
1 ms, and 10 stimuli at 1 Hz) was elicited using a glass
electrode placed adjacent to the cell of interest. Peak
changes in mag-fluo-4 fluorescence for all 10 stimuli
were measured as (Fmax-F0)/F0 and then averaged to
generate a single peak value for each fiber. The rate of
mag-fluo-4 fluorescence decay for the second, third,
and fourth twitches for each fiber was fitted to a firstorder exponential function and the resulting amplitude
and tau values were averaged.Mn2+ quench measurements
Mn2+ quench of fura-2 emission was measured in myo-
tubes loaded with 5 μM fura-2 AM for 1 h at 37°C in
Kreb’s Ringer solution. Briefly, prior to Mn2+ quench
measurements, myotubes (primary cultured cells from
muscle of mice) were treated with 100 μM ryanodine to
block RyR1-mediated Ca2+ release during subsequent
KCl application. Fura-2-loaded myotubes were excited
at the experimentally determined fura-2 isosbestic point
(362 nm) and emission monitored at 510 nm during per-
fusion of 50 mM KCl in the presence of 0.5 mM Mn2+.
Maximum rates of fura-2 quench during KCl application
were determined and evaluated for statistical significance.Calcium imaging in confocal line scan mode in flexor
digitorum brevis muscle fibers stimulated with a single
50 Hz train
To monitor Ca2+ release during electrical stimulation,
FDBs fiber were loaded with 5 μM of mag-fluo-4 AM
for 30 minutes at room temperature in the presence of
20 μM of BTS. Loaded FDBs were placed on the stage of
a confocal microscope with an adapted perfusion system
(tyrode with 20 μM BTS at 0.5 mL/min) and imaged in
line scan mode using the 20x objective (EC Plan-Neofluar)
mounted in the confocal microscope (Zeiss LSM 510
meta, California, United States), one line was acquired
every 1.15 milliseconds (3.66 μsec/pixel time) using the
488 nm excitation laser and the LP 505 emission filter
(Zeiss, California, United States). FDBs were stimulated
with 50 square electrical pulses (200 μsec duration) at
50 Hz and the produced florescence transients was nor-
malized (F/F0) and plotted.Measurement of Ca2+ transients during repetitive
stimulation with 100 Hz trains
Isolated FDB fibers were loaded with 5 μM of mag-fluo-
4-AM for 30 minutes at room temperature, followed by
washout with fresh DMEM (Life technologies, NY,
United States). Electrical stimulation was performed
using two platinum wires placed at each side of the fiber
oriented longitudinally and fatigue was induced with
uninterrupted application of electrical trains (100 Hz,
250 ms, every 1.5 seconds; 0.17 duty cycle) for 300 seconds.
For evaluation of RyR1-releasable SR Ca2+ store content,
1 mM of 4CmC was perfused at 3.25 ml/min, applied after
60 trains of electrical stimulation. Mag-fluo-4 fluorescence
was collected at 20 Hz. Data were collected and analyzed
using Metafluor version 6.2 software (Molecular Devices,
California, United States).
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Muscles were homogenized and lysed in ice-cold RIPA
buffer consisting of (mM): 25 Tris pH 7.6, 150 NaCl, 1
Na3VO4, 10 NaPyroPO4, 10 β-glycerophosphate, 10 NaF,
PMSF, protease inhibitor cocktail (Santa Cruz), 1%
NP40, 1% sodium deoxycholate, and 0.1% SDS (Every
reagents came from Sigma Aldrich, St. Louis, United
States). Equal amounts of total protein from whole
muscle lysates were resolved by electrophoresis, trans-
ferred to PVDF (Millipore, Billercia, United States)
membrane and western blot analyses were performed
using antibodies shown in Additional file 1: Table S1.
LI-COR IRDye™ infrared dyes were used as secondary
antibodies and immunoreactive bands were visualized
using the Odyssey Infrared Imaging System (LI-COR)
(LI-COR Inc, Lincoln, United States). To allow the use
of data from multiple western blots, the fluorescent
band intensity of each band within a single western was
first normalized to GAPDH (Glyceraldehyde 3-phosphate
dehydrogenase) as a loading control and then calculated
as %WT average from that specific western blot. Data
were then pooled to give %WT± SEM.
Co-localization studies and single fiber immunocytochemistry
Single FDB fibers plated on glass slides were fixed with
2% paraformaldehyde in 0.1 M phosphate buffer (PB)
(21.6 mM Na2HPO4 and 81.4 mM NaH2PO4, pH7.2) for
one hour at room temperature, washed twice with phos-
phate buffered saline (PBS) (3.8 mM NaH2PO4, 16.2 mM
Na2HPO4, 150 mM NaCl, pH 7.4), permeabilized, and
blocked in PBS containing 0.5% Triton X-100 and 5% BSA
overnight at 4°C (All reagents come from Sigma Aldrich
as described in Materials). Primary antibodies diluted in
PBST (PBS containing 0.5% TX-100) were added to slides
and incubated overnight at 4°C. After washing twice with
PBS, Alexa-fluor conjugated antibodies were added. Fibers
were washed three times with PBS for 10 minutes
each and mounted in Fluoromount-G (SouthernBiotech,
Birmingham, United States). Fibers were imaged using a
Zeiss LSM 510 META confocal microscope with a
100x/1.30NA oil lens, HeNe 543 nm laser, and Argon
458,477,488,514 laser (Zeiss, California, United States).
Proximity ligation assay
We used proximity ligation assays (PLAs) to identify
proteins that are within 40 Å of each other. PLA was
performed on single FDB fibers plated on glass disks. Fi-
bers were kept at 37°C in a 95% O2-5% CO2 incubator
in DMEM solution supplemented with 10% FBS. Fibers
were then fixed with 2% paraformaldehyde in 0.1 M PB
and incubated with the primary antibodies. The PLA
was performed with the Duolink kit (Olink Biosciences,
Uppsala, Sweden) according to the instruction of the user
manual using an anti-goat MINUS PLA and anti-rabbitPLUS PLA probes and the orange detection reagent (Cy3)
(Olink Biosciences, Uppsala, Sweden). Fibers were imaged
with confocal microscopy (Zeiss LSM 510 META, with
a 100x/1.30NA oil lens and HeNe 543 nm laser). For
analysis, Z stacks were projected and saved as a single
image. The positive spots were counted with Image J
(8-bit images filtered with a Gaussian Blur filter (Rasband,
W.S Image J, U.S. National Institutes of Health, Bethesda,
Maryland, United States), σ = 1, and same threshold per
set adjusted at 15-30). The number of spots counted was
normalized to the area of the fiber estimated from the
width and length of the fiber in the image. For each set of
experiments, the average counts of WT fibers (control)
were set to 100% and the number of spots in each experi-
mental condition was calculated as percentage change.
Insulin treatment
Eight-week-old WT and EK mice were fasted for 12 hours
and then given an intraperitoneal injection of insulin
(1 U/kg) diluted in saline. Control mice were injected
with saline. After 7.5 minutes mice were sacrificed and
muscles (soleus and EDL (Extensor Digitorum Longus))
were isolated, frozen in liquid nitrogen, and stored at −80°C
until use. Muscle levels of pAkt1/2 and pGSK3β in the
presence and absence of insulin were measured as de-
scribed in Butler et al. [23].
Detection of puromycin-labelled proteins
For measurement of protein synthesis we used an in vivo
SUnSET technique [24,25]. Briefly, mice (13 weeks of age)
were food deprived for eight hours. Propofol (18 μl/g)
(Abbott Laboratories, North Chicago, United States) was
administered via an intraperitoneal injection 15 minutes
before the puromycin injection. The mice were then given
an intraperitoneal injection of puromycin (0.04 μmol/g
BW) and sacrificed 35 minutes later. At 10 minutes
before sacrificing, insulin or saline (control) was adminis-
tered via intraperitoneal injection. Muscles were isolated,
homogenized, and prepared for western blotting with
anti-puromycin antibody. For normalization to total
protein, the same western blots were stained with Swift
Membrane Stain™ kit (G-Biosciences, St. Louis, United
States).
Ras activity
Ras activity was measured using a Ras activity assay kit
(Cytoskeleton, Denver, United States). Briefly, muscle was
lysed in buffer and protein concentration was measured.
Raf-Ras binding domain (RBD) beads (50 μl) were added
to the muscle lysates (total 500 μl of 2 mg/ml lysates) and
the mixture was incubated at 4°C on a rotator for one
hour. After incubation, Raf-RBD beads were pelleted by
centrifugation at 5,000 × g at 4°C for one minute and
washed with wash buffer. The bound active Ras was eluted
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Eluted protein was run on 12% gel, transferred to PVDF
membrane, and immunoblotted with Ras-specific anti-
body. The westerns were normalized to the amount of
GAPDH in the muscle lysates (60 μg).
Sarco/endoplasmic reticulum Ca2+-ATPase activity
Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) ac-
tivity in tissue homogenates was performed as described
[26,27].
Electrical stimulation of isolated muscle for signaling
changes
To assess stimulation-induced changes in signaling path-
ways we used the method of Sakamoto et al. [28]. Intact
soleus and EDL muscles were removed and suspended
between a force transducer and stationary anchor within
a test chamber filled with warmed (35°C) Kreb’s Ringer
solution (KRS) oxygenated with a 95/5% mixture of
O2/CO2, as above. After a 30 minute resting equilibration
period, muscles to be stimulated underwent a fatigue
protocol (100 Hz, 200 ms train duration, one second in-
tervals) for five minutes per muscle. At the completion of
the stimulation protocol, rested and stimulated muscles
were immediately frozen in liquid N2 and stored at −80°C.
For muscles treated with KN-93, the drug was added to
the chamber at the start of the 30 minutes equilibration
period, at a final concentration of 5 μM.
Muscle force frequency and fatigue
Intact soleus and EDL muscles were removed and im-
mediately immersed in incubation medium comprised
of KRS (oxygenated with a 95/5% mixture of O2/CO2.
Muscles were tied with sutures at the musculotendinous
junction and suspended between a force transducer and
stationary anchor within a test chamber filled with warmed
(35°C), oxygenated incubation medium. After a 20 minutes
rest to allow mounted muscles to equilibrate, muscle
optimal length (lo) was determined via single-twitch
force generation measurements. Next, force frequency
measurements were obtained at lo using frequencies
from 15 to 300 Hz at 200 ms/train followed by a fatigue
protocol performed over five minutes per muscle. The
specific fatigue protocol for each muscle used was for
the soleus: 15 Hz, 200 ms duration, one second intervals)
and for EDL: 60 Hz, 200 ms duration, one second inter-
vals. Muscle stimulation occurred within the test chamber
using platinum electrodes attached to a Grass S48 stimu-
lator and recorded within Chart5 (version 5.2) software
(eDAQ Inc, Colorado Springs, United States).
Fibertyping with cryosections and immunostaining
Skeletal muscles (soleus and EDL) were dissected, embedded
in OCT compound (Tissue-Tek, Torrance, United States),and frozen in 2-methylbutane (Sigma Aldrich, St. Louis,
United States) precooled in liquid nitrogen. The fro-
zen muscles were sectioned with 10-μm thickness using
a SHANDON cryostat microtome (Thermo Electron
Corporation, Madison, United States). Immunofluorescent
staining was performed using specific antibodies against
myosin heavy chain I (MHCI), IIa (MHCIIa), and IIb
(MHCIIb) (DSHB, Iowa City, USA). Briefly, sections were
rehydrated with PBS for 10 minutes, followed by incuba-
tion at 4°C overnight with MHCI (BA-F8, IgG2b), MHCIIa
(SC-71, IgG1), and/or MHCIIb (BF-F3, IgGM) antibodies
diluted 1:50 in PBS. After washing with PBS, muscle sec-
tions were incubated at room temperature for 90 minutes
with isotype-specific AlexaFluor-594-conjugated goat anti-
mouse IgG2b, AlexaFluor-488-conjugated goat anti-mouse
IgG1, and AlexaFluor-594-conjugated goat anti-mouse
IgGM secondary antibodies diluted 1:200. After three
consecutive washes with PBS, muscle slides were mounted
withVECTASHIELD mounting media (Vector Laboratories,
Burlingame, United States). Images were taken under a
fluorescence microscope (Olympus America, Center Valley,
United States). The relative numbers of the different fiber
types were quantified and normalized by the total number
of muscle fibers per field.
Fiber cross-sectional area
For cross-sectional area (CSA) calculations, 10-μm-thick
frozen sections were obtained from the mid-belly area of
the soleus and EDL muscles. Sections were immuno-
stained for fiber type as described in the previous section,
imaged at 10x magnification through an Olympus DP70
camera (Olympus America, Center Valley, Pennsylvania,
United States), and saved in .tif format. Saved images were
then imported into Photoshop CSE version 10.0 (Adobe
Systems, San Jose, California, United States) for analysis.
First, measurement scale was established by tracing a
within-image scale bar (μm). Next, myofiber CSA was
measured by tracing the external border of individual
myofibers using the Magnetic Lasso tool. Myofibers exhi-
biting evidence of tears or processing artifacts were ex-
cluded from the analysis. Recorded measurements were
then exported into Excel for analysis, with resulting CSA
values reported in μm2.
Statistical analyses
We performed a statistical analyses of two groups using
the Student’s t-test. P <0.05 was considered to be statisti-
cally significant. *P <0.05, **P <0.01, and ***P <0.001
were used to indicate statistical significance.
Results
Creation of EK mice
To explore the role of Ca2+ influx via CaV1.1, we created
mice with a knock-in mutation (E1014K or EK) in the
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lysine residue in the repeat III pore region of CaV1.x
abolishes both Ca2+ binding to this site [29] and divalent
permeation through the channel without altering ECC
[2]. The targeting construct and data confirming the mu-
tation are shown in Additional file 2: Figure S1. Speed
congenics were used to obtain mice on a clean C57BL/6 J
background. The mice were homozygous viable with no
immediately obvious changes in phenotype (see below).
Effects of the EK mutation on myofibrillar Ca2+ handling
To confirm that the EK mutation abolishes Ca2+ influx
through CaV1.1, we compared whole-cell Ca
2+ currents
(Additional file 3: Figure S2A and B) and average CaV1.1
current-voltage relationships (Figure 1A and B) in singleFigure 1 Effects of the EK mutation on CaV1.1 currents, ECC, and ECC
from (A) WT mice (n = 5) and (B) EK mice (n = 9). (C and D) Representative tr
from (C) WT and (D) EK mice. Insets: The first transient for each condition on
(E) Average amplitude and (F) decay constant of the recovery phase in FDB f
fluorescence in myotubes from WT and EK mice. (H) Average rate of Mn2+ qu
altered in EK muscle. Data are shown as mean ± SEM. **P <0.01 and ***P <0.0FDB fibers from EK and WT mice. The EK mutation
abolished inward L-type Ca2+ currents, but permitted
outward monovalent Cs+ currents. The permeation of
EK channels to monovalent cations (for example, Cs+
and Na+; [30]) is unlikely to alter resting membrane
because the EK monovalent cation conductance is only
activated at depolarized potentials. Also, since the activa-
tion kinetics of EK channels is slow [2,30] relative to the
duration of the skeletal muscle action potential, Na+ flux
through EK channels should be minimal, and thus un-
likely to alter action potential properties or intracellular
Na+ levels (approximately 10 mM). The magnitude and
decay kinetics of voltage-gated Ca2+ transients (assessed
using a low affinity Ca2+ indicator, mag-fluo-4 AM) elic-
ited by a low frequency train of electrical stimulationE. Voltage dependence of peak CaV1.1 current density for FDB fibers
aces of electrically-evoked mag-fluo-4 transients in FDB fibers obtained
an expanded time scale in FDB fibers obtained from WT and EK mice.
ibers from WT and EK mice. (G) Representative Mn2+ quench of fura-2
ench in myotubes from WT and EK mice. (I) Scheme of ECC changes
01.
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bers from WT and EK mice (Figure 1C-F), demonstrat-
ing that ECC was not altered by the EK mutation.
We used a well-established Mn2+ quench of fura-2
fluorescence assay to determine the effect of the EK mu-
tation on excitation-coupled Ca2+ entry (ECCE) [31]. In
WT myotubes, membrane depolarization induced by the
addition of 50 mM KCl opens CaV1.1 channels, provid-
ing a pathway for Mn2+ entry to quench fura-2 fluores-
cence (Figure 1G, upper trace), with the maximum slope
of KCl-induced Mn2+ quench directly reflecting Mn2+
entry through CaV1.1 channels (Figure 1H). Since the EK
mutation in the CaV1.1 pore abolishes divalent ion per-
meation through CaV1.1 channels, KCl-induced Mn
2+
quench (ECCE) is absent in myotubes from EK mice
(Figure 1G, lower trace), consistent with ECCE reflecting
Ca2+ entry via CaV1.1, as suggested by Bannister et al.
[32]. The EK fibers also showed a small but significant
increase in baseline Ca2+ influx (Figure 1H).
While the data in Figure 1 indicate that ECC is not
altered in EK fibers, we found significant differences in
the amplitude of the Ca2+ transients during repetitive
stimulation. During a single train of high frequency
stimulation, the amplitude of the Ca2+ transients was
lower in EK compared to WT fibers (Figure 2A and B).
The EK mutation also increased the rate of decline of
the amplitude of the Ca2+ transient during repetitive
trains of high frequency stimulation (Figure 2C). After
these repetitive trains of stimulation, readily releasable
SR Ca2+ stores assessed with a maximal concentration
(1 mM) of 4-chloro-m-cresol (4CmC) were significantly
lower in EK compared to WT fibers (Figure 2D), suggest-
ing greater Ca2+ store depletion in the EK fibers following
repetitive stimulation. However, readily releasable SR Ca2+
stores were not different prior to electrical stimulation
(data not shown).
We used a higher affinity Ca2+ indicator, fura-2 AM,
to measure changes in cytosolic Ca2+ levels. Resting
cytosolic Ca2+ levels did not differ between EK and WT
fibers. However, following stimulation (same stimula-
tion protocol as Figure 2C), cytosolic Ca2+ levels were
higher in both EK and WT fibers (Figure 2E), but mag-
nitude of the stimulation-induced increase in cytosolic
Ca2+ was less in EK fibers. These findings suggest that
Ca2+ permeation through CaV1.1 facilitates refilling of
SR Ca2+ stores either directly or indirectly. The decreased
Ca2+ transient amplitude during repetitive stimulation in
EK fibers could be due to an decrease in Ca2+ influx via
either store-operated or ECCE [31].
Alterations in Ca2+ handling in EK muscle could also
arise from changes in Ca2+ handling proteins. However,
we detected no differences in the expression levels of
CaV1.1, RyR1, SERCA1, or SERCA2 (Figure 3A-E). We
did, however, detect a decrease in calsequestrin (CSQ,antibody detects both CSQ1 and 2) in the soleus (Figure
3F). Sarcolipin levels were unchanged (Figure 3G). SERCA
activity in muscle homogenates at a fixed Ca2+ concentra-
tion was not different between EK and WT muscle
(Figure 3H). However, differences in cytoplasmic Ca2+
levels are likely to impact SERCA activity in intact fibers
during repetitive stimulation.
Pleiotropic effects of the EK mutation on Ca2+-sensitive
pathways
The decreased amplitude of the Ca2+ transient during
repetitive stimulation in EK fibers is likely to impact
multiple muscle Ca2+ signaling pathways. As shown in
Figure 4A, KN-93 decreases the amplitude of the Ca2+
transient in WT but not EK fibers, suggesting a role for
CaMKII. To evaluate the effects of the EK mutation on
CaMKII, we first assessed the ratio of pT286-CaMKII to
total CaMKII using western blotting. Auto-phosphorylation
of CaMKII at T286 is associated with its constitutive activa-
tion [33]. We found that the ratio of p-CaMKII to CaMKII
was decreased in the soleus and EDL of EK mice
(Figure 4B). Since CaMKII is a known integrator of
Ca2+ signals and has an interaction with L-type channels
in other tissues [17], we used immunocytochemistry and
proximity ligation assays (PLA) to determine if CaMKII
was located close to CaV1.1 in skeletal muscle FDB fibers.
We found that a significant amount of CaMKII co-
localizes with CaV1.1 in both WT and EK fibers by im-
munocytochemistry (Figure 4C-E) and by PLA (Figure 4F
and G). As assessed in the PLA assay, the interaction of
CaV1.1 and CaMKII was decreased in the EK compared to
WT fibers under both resting and electrically stimulated
conditions (Figure 4G). Thus, CaMKII is in close proxim-
ity to CaV1.1 and this interaction is decreased by the per-
meation defect in CaV1.1.
We next assessed the effects of inhibition of CaMKII
in WT fibers on refilling of SR Ca2+ stores during repeti-
tive stimulation. We used a specific CaMKII inhibitory
peptide, AIP (myristoylated CaMKII auto-inhibitory pep-
tide) [34], and found that CaMKII inhibition increased
the rate of decline in the amplitude of the Ca2+ tran-
sients (Figure 4H,) and reduced post-stimulation 4CmC
releasable Ca2+ stores (Figure 4I) in FDB fibers from
WT mice. KN-93 (but not the inactive K-92 analog) also
reduced the amplitude of the Ca2+ transients in WT fi-
bers but had no effect in EK fibers (Additional file 3:
Figure S2C and D and Figure 4H). These data suggest
that SR Ca2+ store refilling during repetitive stimulation
in WT fibers is enhanced by CaV1.1-mediated activation
of CaMKII, but this pathway is prevented by the EK mu-
tation in CaV1.1 (Figure 4J).
Ca2+ is required for mTORC1 activation of p70 riboso-
mal S6 kinase 1 (S6K1) [35-39]. To determine if the ab-
sence of Ca2+ permeation through CaV1.1 altered protein
Figure 2 Effects of repetitive stimulation. (A) Representative traces for mag-fluo-4 fluorescence in WT and EK FDB fibers subjected to a single
50 Hz train of stimulation for one second and the response was acquired in the line scan mode of a confocal microscope. (B) Tetanic calcium
response averaged from first to 50th peak (50 pulses for one second) and the calculated averaged response was plotted. (C) Effects of fatiguing
stimulation (100 Hz) on the amplitude of the Ca2+ transients in WT and EK fibers measured with mag-fluo-4. (D) Average amplitude of the 4CmC
releasable Ca2+ stores after repetitive stimulation (100 Hz) measured with mag-fluo-4. (E) Cytosolic Ca2+ concentrations measured with Fura-2 before
and after electrical stimulation using the same stimulation protocol as in (C). Values represent the average values over one second at 30 seconds after
stimulation. Data are shown as mean ± SEM. *P <0.05, **P <0.01, and ***P <0.001.
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protein synthesis in EK and WT muscle. Although we de-
tected a small decrease in protein synthesis in the absence
of insulin in the soleus, protein synthesis was significantly
decreased in both the soleus and EDL muscle of EK mice
treated with insulin compared to insulin-treated WT mice
(Figure 5A-C). To further analyze protein synthesis path-
ways downregulated by the absence of Ca2+ permeation
through CaV1.1, we examined the phosphorylation sta-
tus of several key regulators of protein synthesis. Wefound that pS2448 mTOR, p-T37/T46-4EBP1/4EBP1,
and p-S235/S236-S6/S6 were reduced in the soleus and
EDL of insulin-treated EK mice compared to insulin-
treated WT mice (Figure 5D-F). To identify upstream
events that regulate protein synthesis, we examined the
levels of p-S473-Akt/Akt (phosphorylated by mTORC2)
[40], pT308-Akt/Akt (phosphorylated by PDK1), and
pT202/Y204-ERK1/2 and found that all of these phos-
phorylation events were decreased in both the soleus and
EDL of EK mice treated with insulin compared to the
Figure 3 Ca2+ handling proteins. (A) Representative western blot images of CaV1.1, RyR1, SERCA1, SERCA2, calsequestrin (1 and 2), and
sarcolipin. To allow the use of data in multiple western blots each band within a single western blot was normalized to GAPDH for that sample
as a loading control and then normalized to the average WT values for that particular gel to give %WT. (B) Analysis of muscle levels of CaV1.1
normalized to GAPDH. (C) Analysis of muscle levels of RyR1 normalized to GAPDH. (D) Analysis of muscle levels of SERCA1 normalized to GAPDH.
(E) Analysis of muscle levels of SERCA2 normalized to GAPDH. (F) Analysis of muscle levels of CSQ normalized to GAPDH. (G) Analysis of
sarcolipin normalized to GAPDH. (H) SERCA activity as a function of Ca2+ concentration. (I) Scheme of changes in Ca2+ handling proteins. Values
are shown as mean ± SEM. *P <0.05.
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(Figure 5D, G, and H). Hence the muscle response to
insulin is blunted in the EK mice due to decreased
mTORC2 and PDK1 phosphorylation of Akt and de-
creased ERK1/2 activity (Figure 5I). There are multiple
Ca2+ and/or CaMKII sensitive step(s) upstream of
mTORC2, PDK1, and ERK signaling, especially in the
steps that lead to Ras activation.
The data with and without insulin suggest that the ef-
fects of the EK mutation on insulin-stimulated protein
synthesis involve both Akt phosphorylation (PDK1 and
mTORC2) and ERK signaling. To assess Ras activation
in EK and WT muscle, we pulled down activated Ras
(GTP bound) with Raf-RBD-beads from soleus and EDL
muscle and western blotted with RAS specific antibodyto evaluate the amount of Ras that pulled down. As shown
in Figure 6A and B, less GTP-bound Ras was pulled down
in EK compared to WT muscle. To further assess the role
of Ca2+ permeation and binding to CaV1.1 and activation
of CaMKII in the regulation of these pathways, we isolated
soleus and EDL muscle from WTand EK mice, electrically
stimulated in the presence and absence of KN-93 (an
inhibitor of CaMKII) and again analyzed the pathways
described in Figure 5. Electrical stimulation increased
p-CaMKII/GAPDH, p-Raf/Raf (a CaMKII target), p-ERK1/
2/GAPDH, p-S6/S6, and p-4EBP1/4EBP1 (Figure 6C-L),
and these increases were less in the presence of the CaMKII
inhibitor, KN-93. With the exception of p-Raf/Raf, all of
these changes were detected in both soleus and EDL.
Phosphorylated Raf was detected only at very low levels in
Figure 4 (See legend on next page.)
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Figure 4 Activity-dependent CaMKII translocation and activation. (A) KN-93 decreases the height of the Ca2+ transient during repetitive
stimulation. Tetanic calcium response averaged from first to 50th peak (50 pulses for one second) and the calculated averaged response was
plotted as in Figure 2B. (B) Ratio of p-CaMKII to CaMKII in muscles of EK and WT mice (%WT). Inset: Representative western blot of p-CaMKII and CaMKII.
(C) Representative immunocytochemistry images showing co-localization of CaMKII and CaV1.1 in single WT and EK FDB fibers. (D and E) Representative
line profiles of immunofluorescence for CaMKII and CaV1.1 in (D) WT and (E) EK FDB fibers. (F) Representative images for the PLA assay confirming
a close association of CaMKII with CaV1.1. Scale bar = 20 μm. For negative control (right), normal rabbit IgG was used instead of CaMKII antibody.
(G) Analysis of average spot density in the proximity ligation assay in fiber resting and electrically stimulated. Spots are analyzed in fibers from
three mice of each genotype. (H) Effect of AIP on the amplitude of the Ca2+ transient with repetitive stimulation. (I) 4CmC-induced Ca2+ release
post stimulation in the presence and absence of AIP. (J) Changes associated with the EK mutation in CaV1.1. Values are shown as mean ± SEM.
*P <0.05, **P < 0.01, and ***P < 0.001.
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increases in p-CaMKII/GAPDH, p-Raf/Raf (a CaMKII
target [41]), p-ERK1/2/GAPDH, p-S6/S6, and p-4EBP1/
4EBP1 were detected in the EK muscle subjected to
electrical stimulation.
We also examined the phosphorylation of Akt at S473
and T308 and found that phosphorylation of Akt at these
sites were not significantly increased by electrical stimula-
tion (Additional file 3: Figure S2E-H), suggesting that theFigure 5 Effect of EK mutation on growth signaling pathways. (A) Repre
from EK and WT mice treated with insulin 25 minutes after puromycin. A
anti-puromycin western blot for EDL muscle homogenates from EK and WT m
protein stain as a loading control. (C) Analysis of anti-puromycin/protein in the
blot for protein involved in protein synthesis as %WT average for each western
treated with saline or insulin. (E and F) Analysis of indicated phospho protein to
(G and H) Analysis of indicated phospho protein to dephosphorylated protei
EK mutation alter protein synthesis. Values are shown as mean ± SEM. *P <0.0signaling in response to repetitive stimulation is primarily
through Ras/Raf activation of ERK1/2. Given these find-
ings, we propose that Ca2+ permeation though or binding
to CaV1.1 activates CaMKII which, in turn, phosphorylates
Raf to activate Ras/Raf and ERK1/2. ERK1/2 then activates
mTORC1 (Figure 6M). This stimulation-dependent sig-
naling pathway is strongly blunted in EK muscle.
Together, our data provide compelling evidence that
the EK mutation in CaV1.1 causes significant disruptionsentative anti-puromycin western blot for soleus muscle homogenates
lso shown is a protein stain as a loading control. (B) Representative
ice treated with insulin 25 minutes after puromycin. Also shown is a
soleus and EDL of saline and insulin-treated EK and WT mice. (D) Western
blot using homogenates from the soleus and EDL muscles from mice
dephosphorylated proteins (plotted as %WT average) in soleus and EDL.
n (plotted as %WT average) in soleus and EDL. (I) Pathways altered by the
5 and **P <0.01.
Figure 6 CaV1.1/CaMKII modulates Ras/Raf/ERK1/2 signaling to increase mTORC1 signaling in response to electrical stimulation.
(A) Representative western blot for activated Ras (Ras-GTP) in Raf-RBD pull-down from WT and EK muscle. (B) Analysis of activated Ras
(Ras-GTP) in Raf-RBD pull-down in muscle from WT and EK mice. (C) Electrical stimulation-induced changes in mTORC1 signaling. Representative western
blots of isolated solei and EDL muscles subjected to a five-minute electrical stimulation (as described in Methods) in the presence and absence
of KN-93 (5 μM). For all analyses the values for the western blots of individual bands from WT and EK muscle are each normalized to the values
obtained in the absence of electrical stimulation. For statistical analyses the WT and EK are each compared to their unstimulated controls. (D) Analysis
of pCaMKII/GAPDH in the soleus. (E) Analysis of pCaMKII/GAPDH in the EDL. (F) Analysis of p-Raf (a CaMKII target) in the EDL. (G) Analysis of pERK1/2/
GAPDH in the soleus. (H) Analysis of pERK1/2/GAPDH in the EDL. (I) Analysis of pS6/S6 in the soleus. (J) Analysis of pS6/S6 in the EDL. (K) Analysis of
p4EBP1/4EBP1 in the soleus. (L) Analysis of p4EBP1/4EBP1 in the EDL. (M) Summary of changes in signaling pathways. Values are shown as mean ± SEM.
*P <0.05, **P <0.01, and ***P <0.001.
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muscle, resulting in decreased SR store refilling and a
decline in protein synthesis.
Effects of EK mutation on muscle function
The observed changes in activity dependent Ca2+ hand-
ling, Ca2+-dependent signaling and protein synthesis in
muscle suggest that the EK mutation should alter muscle
function. Although the ability to generate force (normal-
ized to cross-sectional area) was not different between
muscles of young (between eight and 12 weeks of age)
WT and EK mice (Figure 7A and B), both the soleus andthe EDL muscles of young (between eight and 12 weeks
of age) EK mice displayed small, but significant increases
in the rate of fatigue (Figure 7C and D). However, older
mice (over nine months) show significant decreases in
force generation in the soleus (Figure 7E) and further
increases in fatigue in the EDL (Figure 7F). Changes in
muscle force and fatigue could arise from changes in
fiber type distribution. We found that the fraction of fast
twitch type IIb fibers increased and type IIx fibers de-
creased in both soleus and EDL muscle (Figure 7G-J),
but the soleus also showed a decrease in Type 1 fibers
(Figure 7I). A decrease in fiber CSAs in all fiber types in
Figure 7 Muscle function. (A) Force frequency relationship for the soleus of eight-week-old mice. (B) Force- frequency relationship for the EDL
of eight-week-old mice. (C) Fatigue plotted as % initial force in the soleus of eight-week-old mice. (D) Fatigue plotted as % initial force in the
EDL of eight-week-old mice. (E) Force frequency relationship for the soleus of mice over nine months old (F) Fatigue plotted as % initial force in
the EDL of mice over nine months old. (G and H) Representative images from muscle (soleus and EDL, respectively) sections pseudo colored for
the different fiber types are shown. Primary antibodies against MHC I (clone BA-F8) and IIa (clone sc-71) were probed in the same sections to
detect type I (red) and type IIa (green) fibers and antibody for MHC IIb (clone BF-F3) was used in different sections for the detection of type IIb fibers
(red), bar is 100 μm. (I and J) Fiber type distributions in soleus and EDL, respectively. (K and L) Evaluation of average cross-sectional area (CSA) for the
soleus and EDL, respectively. Fibers from seven mice of each genotype were analyzed. Number of individual fibers in soleus measured: type I: 980 (WT),
1,116 (EK); IIA: 1,898 (WT), 1,980 (EK), IIb/x: 417 (WT), 407 (EK). Number of individual fibers in EDL measured: IIA: 612 (WT), 505 (EK), IIb/x: 1,965 (WT),
2,323 (EK). Values in bar graphs are presented as mean ± SEM, n numbers are indicated. *P <0.05, **P <0.01, and ***P <0.001.
Lee et al. Skeletal Muscle  (2015) 5:4 Page 13 of 16both soleus and EDL was also observed in EK compared
to WT mice (Figure 7K and L). We also used a type IIb
specific antibody to separately determine the CSA of
the type IIb fibers in EDL muscles and found a signifi-
cant (P <0.001) decrease of approximately 25% (CSAWT =
1,810 ± 12 μm2, n = 1112 fibers; CSAEK = 1,370 ± 14 μm
2,
n = 898 fibers, each from three different mice). However,
we found no significant differences in grip strength, volun-
tary monitored wheel running, or endurance running in
young (eight to 12 weeks of age) EK compared to WT
mice, suggesting that the effects of the EK mutation on
fiber type distribution, muscle contractility, and fatigue
are relatively mild in young mice but increase in severity
with age.
Discussion
Although acute changes in depolarization-induced con-
traction in low Ca2+ and in the presence of dihydropyri-
dines were previously reported [42], the role of Ca2+permeation through CaV1.1 in skeletal muscle has
largely been ignored because Ca2+ influx through this
channel is not required for ECC [2,43]. We demonstrate
that Ca2+ signaling in skeletal muscle is significantly al-
tered by a permeation defect in CaV1.1 (E1014K, EK).
This mutation resulted in concurrent inhibition of mul-
tiple Ca2+-sensitive pathways. These signaling changes
translated to significant effects on muscle contractile
function, providing compelling evidence that Ca2+ binding
and/or permeation via CaV1.1 is important for maintaining
optimal muscle physiology.
The question that arises is whether the amount of Ca2+
entering the muscle fiber through CaV1.1 is adequate to
directly drive these changes in intracellular Ca2+ handling
during repetitive stimulation. If so, previous studies have
either underestimated the magnitude and relative contri-
bution of Ca2+ influx through CaV1.1 during repetitive
stimulation of muscle, or CaV1.1 Ca
2+ binding and perme-
ation activates a pathway (such as CaMKII) that promotes
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ECCE, SOCE, or TRP). Another possibility is that Ca2+
binding to the selectivity filter triggers a conformational
change in CaV1.1 that drives autophosphorylation of
CaMKII bound to the channel (such as the C-terminus).
CaMKII, activated by this mechanism, would then
modulate multiple Ca2+ handling and downstream sig-
naling pathways (SR Ca2+ stores, Ras, and mTORC1).
The activation of these pathways would then alter nu-
merous aspects of muscle physiology including fatigue,
muscle fiber CSA, type II fiber type specification, and
protein synthesis. Indeed, we demonstrate that auto-
phosphorylation of CaMKII is decreased in the muscle
of EK mice that have undergone repetitive stimulation,
a condition that significantly enhances p-CaMKII levels
in WT muscle.
The activation of different Ca2+-sensitive signaling
pathways depends on the location, frequency, amplitude,
and duration of the Ca2+ signal (reviewed by Tavi and
Westerblad [16]). Important signaling molecules activated
by Ca2+ use different combinations of these mechanisms.
We demonstrate that CaMKII is localized close to CaV1.1
and that the EK mutation decreases the proximity of
CaMKII to CaV1.1. Ca
2+ permeation through CaV1.1, to-
gether with CaMKII activation in WT fibers, slows the de-
cline of the Ca2+ transient with repetitive stimulation by
enhancing Ca2+ store refilling. This mechanism is defi-
cient in fibers from EK mice. CaMKII activation is de-
creased when Ca2+ cannot permeate CaV1.1, suggesting
that Ca2+ binding within and/or movement through the
CaV1.1 pore is important for activation of CaMKII. Recip-
rocally, CaMKII appears to amplify Ca2+ influx (either
through CaV1.1 or a closely associated CaMKII-sensitive
Ca2+ entry channel), since Ca2+ store refilling is decreased
by CaMKII inhibitors in WT, but not EK fibers. However,
at this point it is unclear whether the observed reduction
in activity-dependent SR Ca2+ store content in FDB fibers
from EK mice is due to loss of CaV1.1 Ca
2+ influx or a
downstream effect of CaMKII activation on SR Ca2+ re-
uptake and/or store-operated Ca2+ entry.
One of the major findings in this study was a substan-
tial decrease in insulin-mediated protein synthesis in EK
muscle, as assessed by puromycin labelling and immu-
noblot analysis of the mTOR signaling pathway. The
mTORC1 pathway activation in response to electrical
stimulation is also decreased in EK compared to WT
muscle. Decreased protein synthesis in response to growth
factors such as insulin and repetitive stimulation may
underlie the observed decrease in muscle fiber size in EK
muscle. Activation of downstream substrates of mTORC1
was significantly decreased in EK muscle, as was activation
of the upstream regulators of mTOR, Akt, and ERK1/2.
We suggest that the CaV1.1/CaMKII-dependent event that
modulates insulin-mediated protein synthesis is upstreamof PDK1 and/or mTORC2 activation, since phosphoryl-
ation of both Akt T308 (a PDK1 target) and Akt-S473 (an
mTORC2 target) [44,45] are decreased in EK muscle fol-
lowing insulin treatment. This hypothesis is supported by
previous studies that have reported Ca2+-dependent regu-
lation of the PI3K/Akt/mTOR and Ras/Raf/ERK pathways
[35-39].
The phenotypic changes associated with the EK muta-
tion do not arise from any obvious changes in the
neuromuscular junction. Chen et al. [9] found that a de-
crease in Ca2+ influx associated with a deficiency in the
β-subunit of CaV1.1 altered the formation of the neuro-
muscular junction. This may reflect a recently identified
transcriptional role for the β1a-subunit [46], as opposed
to its more conventional role in controlling CaV1.1 Ca
2+
currents, since mice with the EK mutation in CaV1.1 lack
Ca2+ currents but do not exhibit alterations in neuromus-
cular junction preformatting (Additional file 4: Figure S3).
We also did not detect any changes in immune function
(Additional file 5: Figure S4).
Conclusions
While the magnitude of Ca2+ permeation through CaV1.1
is small, there is a significant impact of this pathway
on muscle function. Changes include increased fatigue,
decreased muscle fiber diameter, increased type IIb
fiber specification, and decreased protein synthesis. Thus,
our results indicate that small changes in CaV1.1 Ca
2+ per-
meation, and CaMKII activation are amplified by changes
in the activity of multiple critical downstream signaling
pathways that impact a broad range of skeletal muscle
functions. We propose that Ca2+ permeation through
CaV1.1, while not required for ECC, modulates multiple
downstream Ca2+-sensitive signaling pathways to improve
muscle function.
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